Concepts (81)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Urinary Incontinence | 1 | 2018 | 47 | 0.610 |
Why?
|
| Erectile Dysfunction | 1 | 2018 | 51 | 0.610 |
Why?
|
| Prostatectomy | 1 | 2018 | 83 | 0.610 |
Why?
|
| Pharmacology | 1 | 2016 | 3 | 0.570 |
Why?
|
| Urethra | 2 | 2019 | 102 | 0.560 |
Why?
|
| Myoblasts | 1 | 2017 | 38 | 0.560 |
Why?
|
| Regenerative Medicine | 2 | 2019 | 201 | 0.490 |
Why?
|
| Biocompatible Materials | 1 | 2016 | 232 | 0.490 |
Why?
|
| Postoperative Complications | 1 | 2018 | 780 | 0.440 |
Why?
|
| Tissue Engineering | 1 | 2016 | 656 | 0.370 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2008 | 199 | 0.350 |
Why?
|
| Chemokine CXCL12 | 2 | 2019 | 25 | 0.330 |
Why?
|
| Apolipoproteins E | 1 | 2008 | 95 | 0.300 |
Why?
|
| Estradiol | 1 | 2008 | 136 | 0.290 |
Why?
|
| Estrogens | 1 | 2008 | 180 | 0.280 |
Why?
|
| Animals | 7 | 2019 | 7541 | 0.260 |
Why?
|
| Atherosclerosis | 1 | 2008 | 766 | 0.200 |
Why?
|
| Primates | 2 | 2019 | 108 | 0.180 |
Why?
|
| Urethral Diseases | 1 | 2019 | 18 | 0.170 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 1022 | 0.170 |
Why?
|
| Endothelial Cells | 2 | 2010 | 189 | 0.170 |
Why?
|
| Sexual Behavior, Animal | 1 | 2018 | 9 | 0.160 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2019 | 65 | 0.160 |
Why?
|
| Urodynamics | 1 | 2018 | 37 | 0.160 |
Why?
|
| Macaca fascicularis | 2 | 2018 | 434 | 0.160 |
Why?
|
| Pelvis | 1 | 2018 | 61 | 0.150 |
Why?
|
| Collagen | 2 | 2017 | 225 | 0.150 |
Why?
|
| Feasibility Studies | 1 | 2018 | 293 | 0.150 |
Why?
|
| Pressure | 1 | 2017 | 51 | 0.140 |
Why?
|
| Social Behavior | 1 | 2017 | 65 | 0.140 |
Why?
|
| Flow Cytometry | 1 | 2017 | 185 | 0.140 |
Why?
|
| Body Weight | 1 | 2017 | 310 | 0.120 |
Why?
|
| Stem Cell Transplantation | 1 | 2016 | 209 | 0.120 |
Why?
|
| Cystitis | 1 | 2010 | 8 | 0.090 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2010 | 14 | 0.090 |
Why?
|
| Radiation Injuries, Experimental | 1 | 2010 | 36 | 0.090 |
Why?
|
| Ovariectomy | 2 | 2008 | 166 | 0.090 |
Why?
|
| Corneal Stroma | 1 | 2010 | 6 | 0.090 |
Why?
|
| Endothelium, Corneal | 1 | 2010 | 22 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2010 | 112 | 0.090 |
Why?
|
| Aging | 1 | 2017 | 946 | 0.090 |
Why?
|
| Neovascularization, Physiologic | 1 | 2010 | 110 | 0.090 |
Why?
|
| Bioengineering | 1 | 2010 | 70 | 0.090 |
Why?
|
| Female | 5 | 2019 | 19959 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2017 | 3306 | 0.080 |
Why?
|
| Urinary Bladder | 1 | 2010 | 182 | 0.080 |
Why?
|
| Tissue Donors | 1 | 2010 | 198 | 0.080 |
Why?
|
| Leukocyte Count | 1 | 2008 | 49 | 0.080 |
Why?
|
| Humans | 4 | 2019 | 32005 | 0.070 |
Why?
|
| Soybean Proteins | 1 | 2008 | 74 | 0.070 |
Why?
|
| Reperfusion Injury | 1 | 2008 | 49 | 0.070 |
Why?
|
| Drug Administration Schedule | 1 | 2008 | 276 | 0.070 |
Why?
|
| Menopause | 1 | 2008 | 95 | 0.070 |
Why?
|
| Dietary Supplements | 1 | 2008 | 185 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 767 | 0.060 |
Why?
|
| Coronary Artery Disease | 1 | 2008 | 401 | 0.060 |
Why?
|
| Mice | 1 | 2008 | 2484 | 0.050 |
Why?
|
| Male | 1 | 2018 | 19165 | 0.050 |
Why?
|
| Injections, Intralesional | 1 | 2019 | 15 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2019 | 406 | 0.040 |
Why?
|
| von Willebrand Factor | 1 | 2010 | 16 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 23 | 0.020 |
Why?
|
| Administration, Intravesical | 1 | 2010 | 24 | 0.020 |
Why?
|
| Rats, Inbred Lew | 1 | 2010 | 118 | 0.020 |
Why?
|
| Fibrosis | 1 | 2010 | 120 | 0.020 |
Why?
|
| Mechanical Phenomena | 1 | 2010 | 28 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 263 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 92 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 463 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2010 | 538 | 0.020 |
Why?
|
| Malondialdehyde | 1 | 2008 | 11 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 2010 | 245 | 0.020 |
Why?
|
| Diet, Atherogenic | 1 | 2008 | 62 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2008 | 78 | 0.020 |
Why?
|
| Peroxidase | 1 | 2008 | 31 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 833 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2010 | 495 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2010 | 604 | 0.020 |
Why?
|
| Isoflavones | 1 | 2008 | 81 | 0.020 |
Why?
|
| Rats | 1 | 2010 | 1595 | 0.020 |
Why?
|
| Time Factors | 1 | 2010 | 2149 | 0.020 |
Why?
|